 Wysłany: Wto 3:37, 15 Lut 2011 Temat postu: WuXi PharmaTech climbs as Goldman starts coverage |
|
| Shares of WuXi PharmaTech Cayman Inc. rose Thursday after a Goldman Sachs analyst started coverage of the stock with a "Buy" rating,Software Localization, and placed WuXi on a list of recommended stocks.
Profits should keep growing over the next two years for the Shanghai-based research and development outsourcing company, said analyst Wei Du. Du said WuXi is in a better competitive position than its rivals, and China may become a top research outsourcing market for drugmakers in developing countries. He put the stock on the "Conviction Buy List,mobile development outsourcing," and WuXi shares gained $1.25,Pharmaceutical software, or 10.3 percent, to $13.40 in afternoon trading. Du said laboratory service revenue should keep growing,Telecommunication outsourcing, while the toxicology service and manufacturing service businesses have good potential over the coming years. "We see strong potential for growth in WuXi‘s manufacturing business in the long term,Telecommunication provider, given its reputation and service quality," he wrote. |
|
